GSK
Director, Clinical Biomarkers, Oncology
GSK, Collegeville, Pennsylvania, United States, 19426
Director, Clinical Biomarkers, Oncology
GSK is seeking a Director of Clinical Biomarkers in Oncology to lead the development and implementation of biomarker and translational medicine strategies that support the clinical development of late‑stage oncology assets.
Key focus for the role:
Designing and executing biomarker strategies, integrating them into clinical plans, collaborating with cross‑functional teams, and driving patient segmentation and enrichment.
Location and Work Arrangements On‑site office 2–3 days a week in the UK (Stevenage) or US (Upper Providence, PA or Waltham, MA).
Responsibilities
Collaborating closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
Validating and implementing biomarker strategies, including target engagement, pharmacodynamic, and proof‑of‑mechanism biomarkers, for clinical‑phase programs to support patient stratification, dose selection, and enable clinical go/no‑go decisions.
Participating in tumor‑specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late‑stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
Representing Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker‑driven decision‑making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives.
Identifying cutting‑edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
Overseeing and/or developing sample testing plans and delivering high‑quality biomarker data packages to inform clinical development and regulatory strategies.
Managing effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
Supporting the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
Contributing to the company’s scientific credibility through publications and presentations.
Basic Qualifications
Minimum of 5 years of experience in the pharmaceutical industry, with a solid background in oncology clinical biomarkers – expertise in late‑phase oncology studies – and translational research within clinical development.
Background as a Scientist and/or Physician.
Proven ability to lead cross‑functional teams and execute strategic biomarker plans.
Experience conducting clinical trials and working as part of clinical study teams.
Expertise in interpreting clinical biomarker data and evaluating innovative biomarker technologies for clinical trial applications.
Strong interpersonal skills and ability to thrive in a team‑oriented environment.
Demonstrated ability to influence teams and key leaders, with a track record of success.
Preferred Qualifications
Experience with high‑dimensional dataset analysis.
Expertise in identifying predictive biomarkers and/or diagnostic development.
Excellent communication, problem‑solving, and presentation skills.
GSK GSK is a global biopharma company focused on joining science, technology, and talent to advance disease treatment. We are committed to creating an environment where our people can thrive and focus on what matters most to patients.
Equal Opportunity Employer Statement GSK is an Equal Opportunity Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or any other category protected by law.
Apply today to help shape the future of oncology research and improve patient outcomes worldwide.
#J-18808-Ljbffr
Key focus for the role:
Designing and executing biomarker strategies, integrating them into clinical plans, collaborating with cross‑functional teams, and driving patient segmentation and enrichment.
Location and Work Arrangements On‑site office 2–3 days a week in the UK (Stevenage) or US (Upper Providence, PA or Waltham, MA).
Responsibilities
Collaborating closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
Validating and implementing biomarker strategies, including target engagement, pharmacodynamic, and proof‑of‑mechanism biomarkers, for clinical‑phase programs to support patient stratification, dose selection, and enable clinical go/no‑go decisions.
Participating in tumor‑specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late‑stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
Representing Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker‑driven decision‑making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives.
Identifying cutting‑edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
Overseeing and/or developing sample testing plans and delivering high‑quality biomarker data packages to inform clinical development and regulatory strategies.
Managing effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
Supporting the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
Contributing to the company’s scientific credibility through publications and presentations.
Basic Qualifications
Minimum of 5 years of experience in the pharmaceutical industry, with a solid background in oncology clinical biomarkers – expertise in late‑phase oncology studies – and translational research within clinical development.
Background as a Scientist and/or Physician.
Proven ability to lead cross‑functional teams and execute strategic biomarker plans.
Experience conducting clinical trials and working as part of clinical study teams.
Expertise in interpreting clinical biomarker data and evaluating innovative biomarker technologies for clinical trial applications.
Strong interpersonal skills and ability to thrive in a team‑oriented environment.
Demonstrated ability to influence teams and key leaders, with a track record of success.
Preferred Qualifications
Experience with high‑dimensional dataset analysis.
Expertise in identifying predictive biomarkers and/or diagnostic development.
Excellent communication, problem‑solving, and presentation skills.
GSK GSK is a global biopharma company focused on joining science, technology, and talent to advance disease treatment. We are committed to creating an environment where our people can thrive and focus on what matters most to patients.
Equal Opportunity Employer Statement GSK is an Equal Opportunity Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or any other category protected by law.
Apply today to help shape the future of oncology research and improve patient outcomes worldwide.
#J-18808-Ljbffr